Lisa Geiselhart

Statistics

Publications

Citations

455

H-Index

Active since

1996

Affiliations

Science Applications International Corporation (United States)(Current)

National Cancer Institute

Frederick National Laboratory for Cancer Research

Albany Medical Center Hospital

Center for Cancer Research

Lisa Geiselhart is an author at Science Applications International Corporation (United States) specializing in immunology, cd8 positive t cells, and immunoregulation.

Publications per year

1996–2001

Publications

IL-7 Administration Alters the CD4:CD8 Ratio, Increases T Cell Numbers, and Increases T Cell Function in the Absence of Activation

Lisa Geiselhart, Courtney A. Humphries, T A Gregorio et al. · The Journal of Immunology · 2001 · 140 citations

Life Sciences, Cell Biology, Immunology +16

IFN-γ and Fas/FasL are required for the antitumor and antiangiogenic effects of IL-12/pulse IL-2 therapy

Jon M. Wigginton, Eilene Gruys, Lisa Geiselhart et al. · Journal of Clinical Investigation · 2001 · 126 citations · Full text

Medicine, Immunology, Oncology +17

IFN-γ and Fas/FasL are required for the antitumor and antiangiogenic effects of IL-12/pulse IL-2 therapy

Jon M. Wigginton, Eilene Gruys, Lisa Geiselhart et al. · Journal of Clinical Investigation · 2001 · 109 citations

Medicine, Immunology, Oncology +17

Inhibition of Human T Lymphoblast Proliferation by Hydroquinone

Qing Li, Lisa Geiselhart, James N. Mittler et al. · Toxicology and Applied Pharmacology · 1996 · 52 citations

Life Sciences, Immunology, Pharmacology +7

The Cigarette Tar Componentp-Benzoquinone Blocks T-Lymphocyte Activation by Inhibiting Interleukin-2 Production, but Not CD25, ICAM-1, or LFA-1 Expression

Lisa Geiselhart, Todd Christian, Fred L. Minnear et al. · Toxicology and Applied Pharmacology · 1997 · 28 citations

Life Sciences, Immunology, Pharmacology +13

1–5 of 5